NexgenRx Inc. (NEGXF)

USD 0.2

(0.0%)

EBITDA Summary of NexgenRx Inc.

  • NexgenRx Inc.'s latest annual EBITDA in 2023 was 1.03 Million USD , down -58.38% from previous year.
  • NexgenRx Inc.'s latest quarterly EBITDA in 2024 Q2 was 186.62 Thousand USD , down -50.84% from previous quarter.
  • NexgenRx Inc. reported an annual EBITDA of 1.24 Million USD in 2022, down -60.16% from previous year.
  • NexgenRx Inc. reported an annual EBITDA of 3.4 Million USD in 2021, up 43.23% from previous year.
  • NexgenRx Inc. reported a quarterly EBITDA of 186.62 Thousand USD for 2024 Q2, down -50.84% from previous quarter.
  • NexgenRx Inc. reported a quarterly EBITDA of 161.6 Thousand USD for 2023 Q2, down -48.9% from previous quarter.

Annual EBITDA Chart of NexgenRx Inc. (2023 - 2015)

Historical Annual EBITDA of NexgenRx Inc. (2023 - 2015)

Year EBITDA EBITDA Growth
2023 1.03 Million USD -58.38%
2022 1.24 Million USD -60.16%
2021 3.4 Million USD 43.23%
2020 1.92 Million USD 249.63%
2019 714.29 Thousand USD 265.53%
2018 -320.55 Thousand USD 3.13%
2017 -342.6 Thousand USD -177.59%
2016 511.85 Thousand USD 352.68%
2015 -174.73 Thousand USD 0.0%

Peer EBITDA Comparison of NexgenRx Inc.

Name EBITDA EBITDA Difference
CarePayment Technologies, Inc. -3.7 Million USD 127.854%
Dong Fang Hui Le Inc. -25.71 Thousand USD 4111.762%
Pacific Health Care Organization, Inc. 716.06 Thousand USD -44.041%